We evaluated the effect of the systemic treatment of G2-β-CD on hepatic changes in male and female homozygous mutant (BALB/cNctr-Npc1m1N, Npc1−/−) mice [20], used as an NPC model. The gene discussed is NPC1; the disease is nasopharyngeal carcinoma.